Kenny the CEO said he feel bad thatfor anyone that over invested and lost all the vc paper. When he gets the FDA to approve the tests all money will be made back in a heartbeat
Not heartbeat, more like heart attack when FDA shoots this submission down.
No data gained from preclinical studies, no animal studies, no papers written about this technology in ANYTHING, let alone JAMA. With all of the high profile MDs this company has name dropped, one would think one of those doctors would have written about the promise of this cutting edge CiaB…….. but none have or ever will. Obsolete, outdated and there are far more technologies (treatments) far more promising.
And so "all money will be made back"? Sounds like a pump and dump to me. Even a PR with the mere mention of FDA approval is close at hand may be enough to jack the share price up. But to make what money back? What money would you be referring to?
And by all means, knock yourself out and buy as much of this garbage as you can. If you wait it may be discounted more.